Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Sexual Function During COVID 19 Pandemic

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04395885
Recruitment Status : Completed
First Posted : May 20, 2020
Last Update Posted : October 6, 2020
Sponsor:
Information provided by (Responsible Party):
Ahmed Mohamed Abbas, Assiut University

Brief Summary:
The outbreak of a new Coronavirus disease (COVID-19), caused by the 2019-nCoV infection in December 2019 is one of the most severe global epidemic health problems.The rapid contagion of this Novel virus has provoked the World Health Organization (WHO) to classifying the outbreak as a "Public Health Emergency of International Concern" on January 30 2020 to a "Pandemic" on March 11th 2020

Condition or disease Intervention/treatment
Sexual Dysfunction Other: Electronic questionnaire

Layout table for study information
Study Type : Observational
Actual Enrollment : 306 participants
Observational Model: Other
Time Perspective: Cross-Sectional
Official Title: Sexual Function Among Egyptian Healthcare Professionals During COVID 19 Pandemic
Actual Study Start Date : June 1, 2020
Actual Primary Completion Date : August 31, 2020
Actual Study Completion Date : September 15, 2020

Group/Cohort Intervention/treatment
study group
health care staff, regardless of gender, who is actively working during the outbreak
Other: Electronic questionnaire
Assess the current sexuality according to the gender using sexual questionnaires for men and women were adapted from the Arabic validated version of the five-item International Index of Erectile Function which is a validated, multidimensional, self-administered questionnaire used for the clinical assessment of erectile dysfunction.and for female Arabic validated version of the Female Sexual Function Index

control group
age matched group of non-health worker individuals.
Other: Electronic questionnaire
Assess the current sexuality according to the gender using sexual questionnaires for men and women were adapted from the Arabic validated version of the five-item International Index of Erectile Function which is a validated, multidimensional, self-administered questionnaire used for the clinical assessment of erectile dysfunction.and for female Arabic validated version of the Female Sexual Function Index




Primary Outcome Measures :
  1. The percentage of study participants diagnosed with sexual dysfunction [ Time Frame: one month ]
    The diagnosis will be made based on the score results



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 40 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population
health care staff, regardless of gender, who is actively working during the outbreak, will be invited to participate in this study by filling anonyms electronic survey. And an age matched group of non-health worker individuals.
Criteria

Inclusion Criteria:

  • health care staff
  • working during the outbreak

Exclusion Criteria:

  • refuse to participate

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04395885


Locations
Layout table for location information
Egypt
Ahmed Abbas
Assiut, Cairo, Egypt, 002
Assiut Faculty of Medicine
Assiut, Egypt
Sponsors and Collaborators
Assiut University
Layout table for additonal information
Responsible Party: Ahmed Mohamed Abbas, Principal investigator, Assiut University
ClinicalTrials.gov Identifier: NCT04395885    
Other Study ID Numbers: SFCOV
First Posted: May 20, 2020    Key Record Dates
Last Update Posted: October 6, 2020
Last Verified: October 2020
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No